Success Metrics

Active Trials
1(17%)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_3
1
17%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Terminated(1)
Other(2)

Detailed Status

Not yet recruiting2
unknown2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

not_yet_recruiting233%
unknown233%
withdrawn117%
active_not_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6